
Sun Pharma Advanced Research Company Limited has informed the Exchange regarding a press release dated February 03, 2026, titled "SPARC Announces Receipt of Priority Review Voucher associated with Sezaby® Approval".
Filed with NSE · · 3 pages · English

Sun Pharma Advanced Research Company Limited has informed the Exchange regarding a press release dated February 03, 2026, titled "SPARC Announces Receipt of Priority Review Voucher associated with Sezaby® Approval".
Sun Pharma Advanced Research Co. Ltd. on 6ix
Follow Sun Pharma Advanced Research into a list and get an email when it puts out news.
Follow Sun Pharma Advanced Research